The aim of this study was to analyse the genetic profiles of metastatic castration-resistant prostate cancer (mCRPC) by using next generation sequencing to identify variants with pathogenic potential in nine DNA repair genes – BRCA1, BRCA2, RAD50, RAD51, RAD51C/D, ATM and ATR.